Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Lianli Ni"'
Publikováno v:
ACS Omega, Vol 9, Iss 17, Pp 19117-19126 (2024)
Externí odkaz:
https://doaj.org/article/1cb3ceea89f443bfb95febc2cf5d5419
Autor:
Lianli Ni, Xinping Zhu, Qi Zhao, Yiwei Shen, Lu Tao, Ji Zhang, Han Lin, Weishan Zhuge, Young-Chang Cho, Ri Cui, Wangyu Zhu
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 51, Iss , Pp 100991- (2024)
Dihydroartemisinin (DHA) exerts an anti-tumor effect in multiple cancers, however, the molecular mechanism of DHA and whether DHA facilitates the anti-tumor efficacy of cisplatin in non-small cell lung cancer (NSCLC) are unclear. Here, we found that
Externí odkaz:
https://doaj.org/article/d6b4acffc0d9427b99355efac9fc43ad
Autor:
LIANLI NI1,2, YUN YU1,2, HAN LIN1,2, WEISHAN ZHUGE2, LU TAO2, YIWEI SHEN2, RI CUI2, SHAOTANG LI1,2 lishaotang163@163.com
Publikováno v:
Biocell. 2023, Vol. 47 Issue 10, p2245-2254. 10p.
Autor:
Wangyu Zhu, Yun Yu, Yuxin Ye, Xinyue Tu, Yan Zhang, Tao Wu, Lianli Ni, Xiangjie Huang, Yumin Wang, Ri Cui
Publikováno v:
Translational Oncology, Vol 37, Iss , Pp 101755- (2023)
Background: Our recent study found that QKI-5 regulated miRNA, miR-196b-5p, promotes non-small cell lung cancer (NSCLC) progression by directly targeting GATA6, TSPAN12 and FAS. However, the biological functions of miR-196b-5p in NSCLC progression an
Externí odkaz:
https://doaj.org/article/5227be1b30cb4591a3cd689db2e739e1
Autor:
Wangyu Zhu, Yun Yu, Kexin Fang, Sisi Xiao, Lianli Ni, Changtian Yin, Xiangjie Huang, Xinchen Wang, Yongkui Zhang, Han‐Bo Le, Ri Cui
Publikováno v:
Cancer Medicine, Vol 12, Iss 4, Pp 4590-4604 (2023)
Abstract Background RNA‐binding protein Quaking‐5 (QKI‐5), a major isoform of QKIs, inhibits tumor progression in non‐small cell lung cancer (NSCLC). However, the underlying molecular mechanisms of QKI‐5 in the cell cycle of NSCLC are still
Externí odkaz:
https://doaj.org/article/5037118217694dfb8cbe3d02bb84548e
Autor:
Wangyu Zhu, Yun Yu, Kexin Fang, Sisi Xiao, Lianli Ni, Changtian Yin, Xiangjie Huang, Xinchen Wang, Yongkui Zhang, Han‐Bo Le, Ri Cui
Publikováno v:
Cancer Medicine. 12:4590-4604
RNA-binding protein Quaking-5 (QKI-5), a major isoform of QKIs, inhibits tumor progression in non-small cell lung cancer (NSCLC). However, the underlying molecular mechanisms of QKI-5 in the cell cycle of NSCLC are still largely unknown.MTT, flow cyt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::185ae14c2b426793781599c3221830cd
https://doi.org/10.1002/cam4.5309
https://doi.org/10.1002/cam4.5309
Autor:
Lianli Ni, Qian Lu, Miao Tang, Lu Tao, Hairong Zhao, Chenggui Zhang, Yun Yu, Xiumei Wu, Heng Liu, Ri Cui
Publikováno v:
Inflammopharmacology. 30(3)
Ulcerative colitis (UC) is a chronic inflammatory bowel disease (IBD) with a low cure rate. Periplaneta americana is a traditional American Cockroach and reportedly has potential therapeutic roles for UC treatment; however, its mechanisms remain uncl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2652ece39198c613be7e10f7cc63da0
https://pubmed.ncbi.nlm.nih.gov/35303235
https://pubmed.ncbi.nlm.nih.gov/35303235
Autor:
Yun Yu, Didi Chen, Tao Wu, Haizhen Lin, Lianli Ni, Hehuan Sui, Sisi Xiao, Canwei Wang, Suping Jiang, Huanle Pan, Shaotang Li, Xiance Jin, Congying Xie, Ri Cui
Publikováno v:
Phytomedicine : international journal of phytotherapy and phytopharmacology. 98
Globally, colorectal cancer (CRC) is one of the leading causes of cancer-related deaths. Oxaliplatin based treatments are frequently used as chemotherapeutic methods for CRC, however, associated side effects and drug resistance often limit their clin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abdd08acb6cccc84c9df644298d49ef7
https://pubmed.ncbi.nlm.nih.gov/35104762
https://pubmed.ncbi.nlm.nih.gov/35104762
Autor:
Zhu, Wangyu1,2 (AUTHOR), Yu, Yun3 (AUTHOR), Fang, Kexin1,2 (AUTHOR), Xiao, Sisi3 (AUTHOR), Ni, Lianli3 (AUTHOR), Yin, Changtian3 (AUTHOR), Huang, Xiangjie3 (AUTHOR), Wang, Xinchen1 (AUTHOR), Zhang, Yongkui2,4 (AUTHOR), Le, Han‐Bo2,4 (AUTHOR) zslehanbo@163.com, Cui, Ri1,3 (AUTHOR) wzmucuiri@163.com
Publikováno v:
Cancer Medicine. Feb2023, Vol. 12 Issue 4, p4590-4604. 15p.
Autor:
Ni, Lianli, Lu, Qian, Tang, Miao, Tao, Lu, Zhao, Hairong, Zhang, Chenggui, Yu, Yun, Wu, Xiumei, Liu, Heng, Cui, Ri
Publikováno v:
Inflammopharmacology; Jun2022, Vol. 30 Issue 3, p907-918, 12p